# Patient Quality of Recovery After TAVR With Different Sedation Regimens

> **NCT07556523** · PHASE4 · RECRUITING · sponsor: **David Lyubashevsky** · enrollment: 126 (estimated)

## Conditions studied

- Transcatheter Aortic Valve Replacement (TAVR)
- Aortic Valve Stenosis

## Interventions

- **DRUG:** Propofol
- **DRUG:** Dexmedetomidine
- **DRUG:** Midazolam
- **DRUG:** Fentanyl

## Key facts

- **NCT ID:** NCT07556523
- **Lead sponsor:** David Lyubashevsky
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-16
- **Primary completion:** 2028-04
- **Final completion:** 2028-06
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07556523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07556523, "Patient Quality of Recovery After TAVR With Different Sedation Regimens". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT07556523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*